NCT00017043View on ClinicalTrials.gov

BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

February 28, 2001

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions

Esophageal CancerGastric Cancer

Interventions

DRUG

ixabepilone

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

Sponsors

Lead Sponsor

Bristol-Myers Squibb

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Bristol-Myers Squibb

INDUSTRY

NCT00017043 - BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy | Biotech Hunter | Biotech Hunter